- Home
- TCRX vs MNSB Comparison
TCRX vs MNSB Comparison
Compare TCRX & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- MNSB
- Stock Information
- Founded
- TCRX 2018
- MNSB 2003
- Country
- TCRX United States
- MNSB United States
- Employees
- TCRX N/A
- MNSB N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- MNSB Major Banks
- Sector
- TCRX Health Care
- MNSB Finance
- Exchange
- TCRX Nasdaq
- MNSB Nasdaq
- Market Cap
- TCRX 115.8M
- MNSB 137.1M
- IPO Year
- TCRX 2021
- MNSB N/A
- Fundamental
- Price
- TCRX $2.17
- MNSB $16.24
- Analyst Decision
- TCRX Strong Buy
- MNSB
- Analyst Count
- TCRX 5
- MNSB 0
- Target Price
- TCRX $11.40
- MNSB N/A
- AVG Volume (30 Days)
- TCRX 382.5K
- MNSB 9.9K
- Earning Date
- TCRX 03-05-2025
- MNSB 01-27-2025
- Dividend Yield
- TCRX N/A
- MNSB 2.46%
- EPS Growth
- TCRX N/A
- MNSB N/A
- EPS
- TCRX N/A
- MNSB N/A
- Revenue
- TCRX $9,362,000.00
- MNSB $59,063,000.00
- Revenue This Year
- TCRX N/A
- MNSB N/A
- Revenue Next Year
- TCRX $5.14
- MNSB $18.30
- P/E Ratio
- TCRX N/A
- MNSB N/A
- Revenue Growth
- TCRX N/A
- MNSB N/A
- 52 Week Low
- TCRX $1.99
- MNSB $14.97
- 52 Week High
- TCRX $9.69
- MNSB $20.88
- Technical
- Relative Strength Index (RSI)
- TCRX 37.12
- MNSB 44.14
- Support Level
- TCRX $2.02
- MNSB $16.28
- Resistance Level
- TCRX $2.17
- MNSB $17.17
- Average True Range (ATR)
- TCRX 0.16
- MNSB 0.31
- MACD
- TCRX 0.02
- MNSB 0.06
- Stochastic Oscillator
- TCRX 26.47
- MNSB 41.57
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.